<DOC>
	<DOCNO>NCT02003898</DOCNO>
	<brief_summary>The purpose study evaluate Threshold Suspend ( TS ) feature Medtronic MiniMed® 530G insulin pump patient 16 old insulin require diabetes .</brief_summary>
	<brief_title>Post Approval Study Threshold Suspend Feature With Medtronic MiniMed® 530G Insulin Pump</brief_title>
	<detailed_description>This Post Approval Study longitudinal , multi-center trial . Up 1,200 subject enrol investigational center across United States . Subjects attend 6 study visit period one year . The study objective demonstrate home use Threshold Suspend ( TS ) associate glycemic deterioration , measure change A1C .</detailed_description>
	<criteria>1 . Subject age 16 old time screen 2 . Subject diagnosed diabetes mellitus least one year prior screen . 3 . Subject currently pump therapy . 4 . Subject transition 530G insulin pump system TS feature turn ON . 5 . Subject willing complete study related activity 6 . Subject willing upload data every 21 day study pump 7 . Subject must Internet access access computer system meet requirement upload pump . This may include use family friend 's computer system Internet access . 8 . Subject able ( insurance financial mean ) cover initial investment ongoing cost 530G insulin pump consumables , CGM , Bayer CONTOUR Next Link RF enable meter supply length study 1 year . 1 . Subject actively participate investigational study ( drug device ) wherein he/she receive treatment investigational study drug investigational study device last 2 week . 2 . Subject woman childbearing potential positive pregnancy test screening plan become pregnant course study 3 . Subject treat hyperthyroidism time screen 4 . Subject abnormality ( &gt; 1.8mg/dL ) creatinine time screen visit 5 . Subject abnormality ( reference range ) thyroidstimulating hormone ( TSH ) time screen visit . If TSH range , Free T3 Free T4 test . Subject may include TSH range long Free T3 Free T4 normal reference range . 6 . Subject take oral , injectable , IV steroid within 8 week time screen visit , plan take oral , injectable , IV steroids course study 7 . Subject currently abuse illicit drug 8 . Subject currently abuse prescription drug 9 . Subject currently abuse alcohol 10 . Subject sickle cell disease hemoglobinopathy 11 . Subject receive red blood cell transfusion erythropoietin within 3 month prior time screen plan receive red blood cell transfusion erythropoietin course study participation 12 . Subject diagnose current eating disorder anorexia bulimia 13 . Subject diagnose chronic kidney disease result chronic anemia 14 . Subject dialysis</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin pump</keyword>
	<keyword>Threshold Suspend</keyword>
</DOC>